nodes	percent_of_prediction	percent_of_DWPC	metapath
Efavirenz—CYP2B6—Simvastatin—atherosclerosis	0.0836	0.115	CbGbCtD
Efavirenz—CYP2C19—Rosuvastatin—atherosclerosis	0.0572	0.0788	CbGbCtD
Efavirenz—CYP2C19—Simvastatin—atherosclerosis	0.0531	0.0732	CbGbCtD
Efavirenz—CYP2C19—Lovastatin—atherosclerosis	0.052	0.0717	CbGbCtD
Efavirenz—CYP2D6—Niacin—atherosclerosis	0.0511	0.0704	CbGbCtD
Efavirenz—CYP2C9—Rosuvastatin—atherosclerosis	0.0475	0.0655	CbGbCtD
Efavirenz—CYP2C9—Simvastatin—atherosclerosis	0.0442	0.0609	CbGbCtD
Efavirenz—CYP2C9—Pravastatin—atherosclerosis	0.0432	0.0596	CbGbCtD
Efavirenz—CYP2C9—Lovastatin—atherosclerosis	0.0432	0.0596	CbGbCtD
Efavirenz—CYP2D6—Simvastatin—atherosclerosis	0.0404	0.0557	CbGbCtD
Efavirenz—CYP2D6—Lovastatin—atherosclerosis	0.0395	0.0545	CbGbCtD
Efavirenz—CYP2D6—Pravastatin—atherosclerosis	0.0395	0.0545	CbGbCtD
Efavirenz—CYP3A4—Rosuvastatin—atherosclerosis	0.0276	0.0381	CbGbCtD
Efavirenz—CYP3A4—Ezetimibe—atherosclerosis	0.0276	0.0381	CbGbCtD
Efavirenz—CYP3A4—Simvastatin—atherosclerosis	0.0257	0.0354	CbGbCtD
Efavirenz—CYP3A4—Pravastatin—atherosclerosis	0.0251	0.0346	CbGbCtD
Efavirenz—CYP3A4—Lovastatin—atherosclerosis	0.0251	0.0346	CbGbCtD
Efavirenz—Alopecia—Simvastatin—atherosclerosis	0.000495	0.00217	CcSEcCtD
Efavirenz—Back pain—Ezetimibe—atherosclerosis	0.000495	0.00217	CcSEcCtD
Efavirenz—Nervous system disorder—Rosuvastatin—atherosclerosis	0.000493	0.00216	CcSEcCtD
Efavirenz—Thrombocytopenia—Rosuvastatin—atherosclerosis	0.000492	0.00215	CcSEcCtD
Efavirenz—Vision blurred—Lovastatin—atherosclerosis	0.000492	0.00215	CcSEcCtD
Efavirenz—Tremor—Lovastatin—atherosclerosis	0.000489	0.00214	CcSEcCtD
Efavirenz—Visual impairment—Pravastatin—atherosclerosis	0.000488	0.00214	CcSEcCtD
Efavirenz—Erythema—Simvastatin—atherosclerosis	0.000488	0.00214	CcSEcCtD
Efavirenz—Ill-defined disorder—Lovastatin—atherosclerosis	0.000484	0.00212	CcSEcCtD
Efavirenz—Eye disorder—Niacin—atherosclerosis	0.000481	0.00211	CcSEcCtD
Efavirenz—Flatulence—Simvastatin—atherosclerosis	0.000481	0.00211	CcSEcCtD
Efavirenz—Tinnitus—Niacin—atherosclerosis	0.00048	0.0021	CcSEcCtD
Efavirenz—Erythema multiforme—Pravastatin—atherosclerosis	0.000479	0.0021	CcSEcCtD
Efavirenz—Dysgeusia—Simvastatin—atherosclerosis	0.000478	0.00209	CcSEcCtD
Efavirenz—Flushing—Niacin—atherosclerosis	0.000478	0.00209	CcSEcCtD
Efavirenz—Angioedema—Lovastatin—atherosclerosis	0.000477	0.00209	CcSEcCtD
Efavirenz—Ill-defined disorder—Ezetimibe—atherosclerosis	0.000475	0.00208	CcSEcCtD
Efavirenz—Anaemia—Ezetimibe—atherosclerosis	0.000473	0.00207	CcSEcCtD
Efavirenz—Tinnitus—Pravastatin—atherosclerosis	0.000472	0.00207	CcSEcCtD
Efavirenz—Malaise—Lovastatin—atherosclerosis	0.00047	0.00206	CcSEcCtD
Efavirenz—Flushing—Pravastatin—atherosclerosis	0.00047	0.00206	CcSEcCtD
Efavirenz—Cardiac disorder—Pravastatin—atherosclerosis	0.00047	0.00206	CcSEcCtD
Efavirenz—Vertigo—Lovastatin—atherosclerosis	0.000469	0.00205	CcSEcCtD
Efavirenz—Angioedema—Ezetimibe—atherosclerosis	0.000467	0.00205	CcSEcCtD
Efavirenz—Angiopathy—Niacin—atherosclerosis	0.000467	0.00205	CcSEcCtD
Efavirenz—Malaise—Ezetimibe—atherosclerosis	0.000461	0.00202	CcSEcCtD
Efavirenz—Vision blurred—Simvastatin—atherosclerosis	0.00046	0.00201	CcSEcCtD
Efavirenz—Arrhythmia—Niacin—atherosclerosis	0.00046	0.00201	CcSEcCtD
Efavirenz—Musculoskeletal discomfort—Rosuvastatin—atherosclerosis	0.000458	0.00201	CcSEcCtD
Efavirenz—Tremor—Simvastatin—atherosclerosis	0.000457	0.002	CcSEcCtD
Efavirenz—Alopecia—Niacin—atherosclerosis	0.000455	0.00199	CcSEcCtD
Efavirenz—Insomnia—Rosuvastatin—atherosclerosis	0.000454	0.00199	CcSEcCtD
Efavirenz—Ill-defined disorder—Simvastatin—atherosclerosis	0.000453	0.00198	CcSEcCtD
Efavirenz—Arrhythmia—Pravastatin—atherosclerosis	0.000453	0.00198	CcSEcCtD
Efavirenz—Palpitations—Ezetimibe—atherosclerosis	0.000452	0.00198	CcSEcCtD
Efavirenz—Paraesthesia—Rosuvastatin—atherosclerosis	0.000451	0.00198	CcSEcCtD
Efavirenz—Anaemia—Simvastatin—atherosclerosis	0.000451	0.00198	CcSEcCtD
Efavirenz—Erythema—Niacin—atherosclerosis	0.000448	0.00196	CcSEcCtD
Efavirenz—Malnutrition—Niacin—atherosclerosis	0.000448	0.00196	CcSEcCtD
Efavirenz—Alopecia—Pravastatin—atherosclerosis	0.000448	0.00196	CcSEcCtD
Efavirenz—Cough—Ezetimibe—atherosclerosis	0.000446	0.00196	CcSEcCtD
Efavirenz—Angioedema—Simvastatin—atherosclerosis	0.000446	0.00195	CcSEcCtD
Efavirenz—Myalgia—Lovastatin—atherosclerosis	0.000444	0.00195	CcSEcCtD
Efavirenz—Chest pain—Lovastatin—atherosclerosis	0.000444	0.00195	CcSEcCtD
Efavirenz—Arthralgia—Lovastatin—atherosclerosis	0.000444	0.00195	CcSEcCtD
Efavirenz—Anxiety—Lovastatin—atherosclerosis	0.000442	0.00194	CcSEcCtD
Efavirenz—Dyspepsia—Rosuvastatin—atherosclerosis	0.000442	0.00194	CcSEcCtD
Efavirenz—Hypertension—Ezetimibe—atherosclerosis	0.000442	0.00194	CcSEcCtD
Efavirenz—Flatulence—Niacin—atherosclerosis	0.000441	0.00193	CcSEcCtD
Efavirenz—Malaise—Simvastatin—atherosclerosis	0.00044	0.00193	CcSEcCtD
Efavirenz—Tension—Niacin—atherosclerosis	0.00044	0.00193	CcSEcCtD
Efavirenz—Discomfort—Lovastatin—atherosclerosis	0.000439	0.00192	CcSEcCtD
Efavirenz—Vertigo—Simvastatin—atherosclerosis	0.000438	0.00192	CcSEcCtD
Efavirenz—Chest pain—Ezetimibe—atherosclerosis	0.000435	0.00191	CcSEcCtD
Efavirenz—Arthralgia—Ezetimibe—atherosclerosis	0.000435	0.00191	CcSEcCtD
Efavirenz—Myalgia—Ezetimibe—atherosclerosis	0.000435	0.00191	CcSEcCtD
Efavirenz—Nervousness—Niacin—atherosclerosis	0.000435	0.00191	CcSEcCtD
Efavirenz—Flatulence—Pravastatin—atherosclerosis	0.000435	0.0019	CcSEcCtD
Efavirenz—Dry mouth—Lovastatin—atherosclerosis	0.000434	0.0019	CcSEcCtD
Efavirenz—Tension—Pravastatin—atherosclerosis	0.000433	0.0019	CcSEcCtD
Efavirenz—Unspecified disorder of skin and subcutaneous tissue—Ezetimibe—atherosclerosis	0.000432	0.0019	CcSEcCtD
Efavirenz—Dysgeusia—Pravastatin—atherosclerosis	0.000432	0.00189	CcSEcCtD
Efavirenz—Discomfort—Ezetimibe—atherosclerosis	0.00043	0.00189	CcSEcCtD
Efavirenz—Pain—Rosuvastatin—atherosclerosis	0.000429	0.00188	CcSEcCtD
Efavirenz—Constipation—Rosuvastatin—atherosclerosis	0.000429	0.00188	CcSEcCtD
Efavirenz—Confusional state—Lovastatin—atherosclerosis	0.000429	0.00188	CcSEcCtD
Efavirenz—Nervousness—Pravastatin—atherosclerosis	0.000428	0.00188	CcSEcCtD
Efavirenz—Dry mouth—Ezetimibe—atherosclerosis	0.000426	0.00187	CcSEcCtD
Efavirenz—Vision blurred—Niacin—atherosclerosis	0.000422	0.00185	CcSEcCtD
Efavirenz—Confusional state—Ezetimibe—atherosclerosis	0.000421	0.00184	CcSEcCtD
Efavirenz—Thrombocytopenia—Lovastatin—atherosclerosis	0.000417	0.00183	CcSEcCtD
Efavirenz—Vision blurred—Pravastatin—atherosclerosis	0.000416	0.00182	CcSEcCtD
Efavirenz—Chest pain—Simvastatin—atherosclerosis	0.000415	0.00182	CcSEcCtD
Efavirenz—Myalgia—Simvastatin—atherosclerosis	0.000415	0.00182	CcSEcCtD
Efavirenz—Arthralgia—Simvastatin—atherosclerosis	0.000415	0.00182	CcSEcCtD
Efavirenz—Feeling abnormal—Rosuvastatin—atherosclerosis	0.000414	0.00181	CcSEcCtD
Efavirenz—Anxiety—Simvastatin—atherosclerosis	0.000414	0.00181	CcSEcCtD
Efavirenz—Tremor—Pravastatin—atherosclerosis	0.000413	0.00181	CcSEcCtD
Efavirenz—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.000411	0.0018	CcSEcCtD
Efavirenz—Discomfort—Simvastatin—atherosclerosis	0.00041	0.0018	CcSEcCtD
Efavirenz—Nervous system disorder—Ezetimibe—atherosclerosis	0.000409	0.00179	CcSEcCtD
Efavirenz—Angioedema—Niacin—atherosclerosis	0.000409	0.00179	CcSEcCtD
Efavirenz—Ill-defined disorder—Pravastatin—atherosclerosis	0.000409	0.00179	CcSEcCtD
Efavirenz—Thrombocytopenia—Ezetimibe—atherosclerosis	0.000409	0.00179	CcSEcCtD
Efavirenz—Anaemia—Pravastatin—atherosclerosis	0.000408	0.00179	CcSEcCtD
Efavirenz—Anorexia—Lovastatin—atherosclerosis	0.000406	0.00178	CcSEcCtD
Efavirenz—Skin disorder—Ezetimibe—atherosclerosis	0.000406	0.00178	CcSEcCtD
Efavirenz—Angioedema—Pravastatin—atherosclerosis	0.000403	0.00177	CcSEcCtD
Efavirenz—Vertigo—Niacin—atherosclerosis	0.000402	0.00176	CcSEcCtD
Efavirenz—Syncope—Niacin—atherosclerosis	0.000402	0.00176	CcSEcCtD
Efavirenz—Confusional state—Simvastatin—atherosclerosis	0.000401	0.00176	CcSEcCtD
Efavirenz—Urticaria—Rosuvastatin—atherosclerosis	0.000399	0.00175	CcSEcCtD
Efavirenz—Malaise—Pravastatin—atherosclerosis	0.000398	0.00174	CcSEcCtD
Efavirenz—Abdominal pain—Rosuvastatin—atherosclerosis	0.000397	0.00174	CcSEcCtD
Efavirenz—Vertigo—Pravastatin—atherosclerosis	0.000396	0.00174	CcSEcCtD
Efavirenz—Palpitations—Niacin—atherosclerosis	0.000396	0.00173	CcSEcCtD
Efavirenz—Loss of consciousness—Niacin—atherosclerosis	0.000394	0.00173	CcSEcCtD
Efavirenz—Cough—Niacin—atherosclerosis	0.000391	0.00171	CcSEcCtD
Efavirenz—Thrombocytopenia—Simvastatin—atherosclerosis	0.00039	0.00171	CcSEcCtD
Efavirenz—Musculoskeletal discomfort—Lovastatin—atherosclerosis	0.000388	0.0017	CcSEcCtD
Efavirenz—Insomnia—Lovastatin—atherosclerosis	0.000385	0.00169	CcSEcCtD
Efavirenz—Cough—Pravastatin—atherosclerosis	0.000385	0.00169	CcSEcCtD
Efavirenz—Paraesthesia—Lovastatin—atherosclerosis	0.000382	0.00167	CcSEcCtD
Efavirenz—Myalgia—Niacin—atherosclerosis	0.000381	0.00167	CcSEcCtD
Efavirenz—Arthralgia—Niacin—atherosclerosis	0.000381	0.00167	CcSEcCtD
Efavirenz—Hypertension—Pravastatin—atherosclerosis	0.000381	0.00167	CcSEcCtD
Efavirenz—Musculoskeletal discomfort—Ezetimibe—atherosclerosis	0.00038	0.00167	CcSEcCtD
Efavirenz—Anorexia—Simvastatin—atherosclerosis	0.000379	0.00166	CcSEcCtD
Efavirenz—Dyspnoea—Lovastatin—atherosclerosis	0.000379	0.00166	CcSEcCtD
Efavirenz—Unspecified disorder of skin and subcutaneous tissue—Niacin—atherosclerosis	0.000379	0.00166	CcSEcCtD
Efavirenz—Insomnia—Ezetimibe—atherosclerosis	0.000378	0.00165	CcSEcCtD
Efavirenz—Chest pain—Pravastatin—atherosclerosis	0.000375	0.00165	CcSEcCtD
Efavirenz—Myalgia—Pravastatin—atherosclerosis	0.000375	0.00165	CcSEcCtD
Efavirenz—Arthralgia—Pravastatin—atherosclerosis	0.000375	0.00165	CcSEcCtD
Efavirenz—Paraesthesia—Ezetimibe—atherosclerosis	0.000375	0.00164	CcSEcCtD
Efavirenz—Dyspepsia—Lovastatin—atherosclerosis	0.000375	0.00164	CcSEcCtD
Efavirenz—Anxiety—Pravastatin—atherosclerosis	0.000374	0.00164	CcSEcCtD
Efavirenz—Dry mouth—Niacin—atherosclerosis	0.000373	0.00163	CcSEcCtD
Efavirenz—Dyspnoea—Ezetimibe—atherosclerosis	0.000372	0.00163	CcSEcCtD
Efavirenz—Discomfort—Pravastatin—atherosclerosis	0.000371	0.00163	CcSEcCtD
Efavirenz—Hypersensitivity—Rosuvastatin—atherosclerosis	0.00037	0.00162	CcSEcCtD
Efavirenz—Decreased appetite—Lovastatin—atherosclerosis	0.00037	0.00162	CcSEcCtD
Efavirenz—Dyspepsia—Ezetimibe—atherosclerosis	0.000367	0.00161	CcSEcCtD
Efavirenz—Fatigue—Lovastatin—atherosclerosis	0.000367	0.00161	CcSEcCtD
Efavirenz—Pain—Lovastatin—atherosclerosis	0.000364	0.00159	CcSEcCtD
Efavirenz—Constipation—Lovastatin—atherosclerosis	0.000364	0.00159	CcSEcCtD
Efavirenz—Confusional state—Pravastatin—atherosclerosis	0.000363	0.00159	CcSEcCtD
Efavirenz—Decreased appetite—Ezetimibe—atherosclerosis	0.000363	0.00159	CcSEcCtD
Efavirenz—Musculoskeletal discomfort—Simvastatin—atherosclerosis	0.000363	0.00159	CcSEcCtD
Efavirenz—Gastrointestinal disorder—Ezetimibe—atherosclerosis	0.00036	0.00158	CcSEcCtD
Efavirenz—Asthenia—Rosuvastatin—atherosclerosis	0.00036	0.00158	CcSEcCtD
Efavirenz—Insomnia—Simvastatin—atherosclerosis	0.00036	0.00158	CcSEcCtD
Efavirenz—Fatigue—Ezetimibe—atherosclerosis	0.00036	0.00158	CcSEcCtD
Efavirenz—Shock—Niacin—atherosclerosis	0.00036	0.00158	CcSEcCtD
Efavirenz—Paraesthesia—Simvastatin—atherosclerosis	0.000357	0.00157	CcSEcCtD
Efavirenz—Constipation—Ezetimibe—atherosclerosis	0.000357	0.00156	CcSEcCtD
Efavirenz—Pain—Ezetimibe—atherosclerosis	0.000357	0.00156	CcSEcCtD
Efavirenz—Tachycardia—Niacin—atherosclerosis	0.000357	0.00156	CcSEcCtD
Efavirenz—Pruritus—Rosuvastatin—atherosclerosis	0.000355	0.00156	CcSEcCtD
Efavirenz—Skin disorder—Niacin—atherosclerosis	0.000355	0.00156	CcSEcCtD
Efavirenz—Dyspnoea—Simvastatin—atherosclerosis	0.000355	0.00156	CcSEcCtD
Efavirenz—Hyperhidrosis—Niacin—atherosclerosis	0.000353	0.00155	CcSEcCtD
Efavirenz—Thrombocytopenia—Pravastatin—atherosclerosis	0.000352	0.00154	CcSEcCtD
Efavirenz—Feeling abnormal—Lovastatin—atherosclerosis	0.000351	0.00154	CcSEcCtD
Efavirenz—Dyspepsia—Simvastatin—atherosclerosis	0.00035	0.00154	CcSEcCtD
Efavirenz—Anorexia—Niacin—atherosclerosis	0.000348	0.00153	CcSEcCtD
Efavirenz—Gastrointestinal pain—Lovastatin—atherosclerosis	0.000348	0.00153	CcSEcCtD
Efavirenz—Hyperhidrosis—Pravastatin—atherosclerosis	0.000348	0.00152	CcSEcCtD
Efavirenz—Decreased appetite—Simvastatin—atherosclerosis	0.000346	0.00152	CcSEcCtD
Efavirenz—Feeling abnormal—Ezetimibe—atherosclerosis	0.000344	0.00151	CcSEcCtD
Efavirenz—Gastrointestinal disorder—Simvastatin—atherosclerosis	0.000344	0.00151	CcSEcCtD
Efavirenz—Diarrhoea—Rosuvastatin—atherosclerosis	0.000344	0.00151	CcSEcCtD
Efavirenz—Fatigue—Simvastatin—atherosclerosis	0.000343	0.0015	CcSEcCtD
Efavirenz—Anorexia—Pravastatin—atherosclerosis	0.000343	0.0015	CcSEcCtD
Efavirenz—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.000341	0.0015	CcSEcCtD
Efavirenz—Pain—Simvastatin—atherosclerosis	0.00034	0.00149	CcSEcCtD
Efavirenz—Constipation—Simvastatin—atherosclerosis	0.00034	0.00149	CcSEcCtD
Efavirenz—Urticaria—Lovastatin—atherosclerosis	0.000338	0.00148	CcSEcCtD
Efavirenz—Abdominal pain—Lovastatin—atherosclerosis	0.000336	0.00147	CcSEcCtD
Efavirenz—Body temperature increased—Lovastatin—atherosclerosis	0.000336	0.00147	CcSEcCtD
Efavirenz—Musculoskeletal discomfort—Niacin—atherosclerosis	0.000333	0.00146	CcSEcCtD
Efavirenz—Dizziness—Rosuvastatin—atherosclerosis	0.000332	0.00146	CcSEcCtD
Efavirenz—Urticaria—Ezetimibe—atherosclerosis	0.000332	0.00145	CcSEcCtD
Efavirenz—Insomnia—Niacin—atherosclerosis	0.000331	0.00145	CcSEcCtD
Efavirenz—Abdominal pain—Ezetimibe—atherosclerosis	0.00033	0.00145	CcSEcCtD
Efavirenz—Body temperature increased—Ezetimibe—atherosclerosis	0.00033	0.00145	CcSEcCtD
Efavirenz—Paraesthesia—Niacin—atherosclerosis	0.000328	0.00144	CcSEcCtD
Efavirenz—Feeling abnormal—Simvastatin—atherosclerosis	0.000328	0.00144	CcSEcCtD
Efavirenz—Musculoskeletal discomfort—Pravastatin—atherosclerosis	0.000328	0.00144	CcSEcCtD
Efavirenz—Dyspnoea—Niacin—atherosclerosis	0.000326	0.00143	CcSEcCtD
Efavirenz—Gastrointestinal pain—Simvastatin—atherosclerosis	0.000326	0.00143	CcSEcCtD
Efavirenz—Insomnia—Pravastatin—atherosclerosis	0.000326	0.00143	CcSEcCtD
Efavirenz—Somnolence—Niacin—atherosclerosis	0.000325	0.00142	CcSEcCtD
Efavirenz—Paraesthesia—Pravastatin—atherosclerosis	0.000323	0.00142	CcSEcCtD
Efavirenz—Dyspepsia—Niacin—atherosclerosis	0.000322	0.00141	CcSEcCtD
Efavirenz—Dyspnoea—Pravastatin—atherosclerosis	0.000321	0.00141	CcSEcCtD
Efavirenz—Decreased appetite—Niacin—atherosclerosis	0.000318	0.00139	CcSEcCtD
Efavirenz—Dyspepsia—Pravastatin—atherosclerosis	0.000317	0.00139	CcSEcCtD
Efavirenz—Rash—Rosuvastatin—atherosclerosis	0.000317	0.00139	CcSEcCtD
Efavirenz—Dermatitis—Rosuvastatin—atherosclerosis	0.000316	0.00139	CcSEcCtD
Efavirenz—Urticaria—Simvastatin—atherosclerosis	0.000316	0.00139	CcSEcCtD
Efavirenz—Gastrointestinal disorder—Niacin—atherosclerosis	0.000316	0.00138	CcSEcCtD
Efavirenz—Abdominal pain—Simvastatin—atherosclerosis	0.000315	0.00138	CcSEcCtD
Efavirenz—Body temperature increased—Simvastatin—atherosclerosis	0.000315	0.00138	CcSEcCtD
Efavirenz—Headache—Rosuvastatin—atherosclerosis	0.000315	0.00138	CcSEcCtD
Efavirenz—Hypersensitivity—Lovastatin—atherosclerosis	0.000314	0.00137	CcSEcCtD
Efavirenz—Decreased appetite—Pravastatin—atherosclerosis	0.000313	0.00137	CcSEcCtD
Efavirenz—Pain—Niacin—atherosclerosis	0.000313	0.00137	CcSEcCtD
Efavirenz—Fatigue—Pravastatin—atherosclerosis	0.00031	0.00136	CcSEcCtD
Efavirenz—Pain—Pravastatin—atherosclerosis	0.000308	0.00135	CcSEcCtD
Efavirenz—Constipation—Pravastatin—atherosclerosis	0.000308	0.00135	CcSEcCtD
Efavirenz—Hypersensitivity—Ezetimibe—atherosclerosis	0.000308	0.00135	CcSEcCtD
Efavirenz—Asthenia—Lovastatin—atherosclerosis	0.000305	0.00134	CcSEcCtD
Efavirenz—Pruritus—Lovastatin—atherosclerosis	0.000301	0.00132	CcSEcCtD
Efavirenz—Asthenia—Ezetimibe—atherosclerosis	0.0003	0.00131	CcSEcCtD
Efavirenz—Gastrointestinal pain—Niacin—atherosclerosis	0.000299	0.00131	CcSEcCtD
Efavirenz—Nausea—Rosuvastatin—atherosclerosis	0.000298	0.00131	CcSEcCtD
Efavirenz—Feeling abnormal—Pravastatin—atherosclerosis	0.000297	0.0013	CcSEcCtD
Efavirenz—Pruritus—Ezetimibe—atherosclerosis	0.000295	0.00129	CcSEcCtD
Efavirenz—Gastrointestinal pain—Pravastatin—atherosclerosis	0.000294	0.00129	CcSEcCtD
Efavirenz—Hypersensitivity—Simvastatin—atherosclerosis	0.000293	0.00129	CcSEcCtD
Efavirenz—Diarrhoea—Lovastatin—atherosclerosis	0.000291	0.00128	CcSEcCtD
Efavirenz—Urticaria—Niacin—atherosclerosis	0.00029	0.00127	CcSEcCtD
Efavirenz—Body temperature increased—Niacin—atherosclerosis	0.000289	0.00127	CcSEcCtD
Efavirenz—Abdominal pain—Niacin—atherosclerosis	0.000289	0.00127	CcSEcCtD
Efavirenz—Urticaria—Pravastatin—atherosclerosis	0.000286	0.00125	CcSEcCtD
Efavirenz—Asthenia—Simvastatin—atherosclerosis	0.000286	0.00125	CcSEcCtD
Efavirenz—Diarrhoea—Ezetimibe—atherosclerosis	0.000286	0.00125	CcSEcCtD
Efavirenz—Abdominal pain—Pravastatin—atherosclerosis	0.000285	0.00125	CcSEcCtD
Efavirenz—Body temperature increased—Pravastatin—atherosclerosis	0.000285	0.00125	CcSEcCtD
Efavirenz—Pruritus—Simvastatin—atherosclerosis	0.000282	0.00123	CcSEcCtD
Efavirenz—Dizziness—Lovastatin—atherosclerosis	0.000281	0.00123	CcSEcCtD
Efavirenz—Dizziness—Ezetimibe—atherosclerosis	0.000276	0.00121	CcSEcCtD
Efavirenz—Diarrhoea—Simvastatin—atherosclerosis	0.000272	0.00119	CcSEcCtD
Efavirenz—Vomiting—Lovastatin—atherosclerosis	0.000271	0.00119	CcSEcCtD
Efavirenz—Hypersensitivity—Niacin—atherosclerosis	0.000269	0.00118	CcSEcCtD
Efavirenz—Rash—Lovastatin—atherosclerosis	0.000268	0.00118	CcSEcCtD
Efavirenz—Dermatitis—Lovastatin—atherosclerosis	0.000268	0.00117	CcSEcCtD
Efavirenz—Headache—Lovastatin—atherosclerosis	0.000267	0.00117	CcSEcCtD
Efavirenz—Vomiting—Ezetimibe—atherosclerosis	0.000265	0.00116	CcSEcCtD
Efavirenz—Hypersensitivity—Pravastatin—atherosclerosis	0.000265	0.00116	CcSEcCtD
Efavirenz—Dizziness—Simvastatin—atherosclerosis	0.000263	0.00115	CcSEcCtD
Efavirenz—Rash—Ezetimibe—atherosclerosis	0.000263	0.00115	CcSEcCtD
Efavirenz—Dermatitis—Ezetimibe—atherosclerosis	0.000263	0.00115	CcSEcCtD
Efavirenz—Asthenia—Niacin—atherosclerosis	0.000262	0.00115	CcSEcCtD
Efavirenz—Headache—Ezetimibe—atherosclerosis	0.000262	0.00115	CcSEcCtD
Efavirenz—Pruritus—Niacin—atherosclerosis	0.000259	0.00113	CcSEcCtD
Efavirenz—Asthenia—Pravastatin—atherosclerosis	0.000258	0.00113	CcSEcCtD
Efavirenz—Pruritus—Pravastatin—atherosclerosis	0.000255	0.00112	CcSEcCtD
Efavirenz—Vomiting—Simvastatin—atherosclerosis	0.000253	0.00111	CcSEcCtD
Efavirenz—Nausea—Lovastatin—atherosclerosis	0.000253	0.00111	CcSEcCtD
Efavirenz—Rash—Simvastatin—atherosclerosis	0.000251	0.0011	CcSEcCtD
Efavirenz—Dermatitis—Simvastatin—atherosclerosis	0.000251	0.0011	CcSEcCtD
Efavirenz—Diarrhoea—Niacin—atherosclerosis	0.00025	0.0011	CcSEcCtD
Efavirenz—Headache—Simvastatin—atherosclerosis	0.000249	0.00109	CcSEcCtD
Efavirenz—Nausea—Ezetimibe—atherosclerosis	0.000248	0.00109	CcSEcCtD
Efavirenz—Diarrhoea—Pravastatin—atherosclerosis	0.000246	0.00108	CcSEcCtD
Efavirenz—Dizziness—Niacin—atherosclerosis	0.000242	0.00106	CcSEcCtD
Efavirenz—Dizziness—Pravastatin—atherosclerosis	0.000238	0.00104	CcSEcCtD
Efavirenz—Nausea—Simvastatin—atherosclerosis	0.000236	0.00104	CcSEcCtD
Efavirenz—Vomiting—Niacin—atherosclerosis	0.000232	0.00102	CcSEcCtD
Efavirenz—Rash—Niacin—atherosclerosis	0.00023	0.00101	CcSEcCtD
Efavirenz—Dermatitis—Niacin—atherosclerosis	0.00023	0.00101	CcSEcCtD
Efavirenz—Headache—Niacin—atherosclerosis	0.000229	0.001	CcSEcCtD
Efavirenz—Vomiting—Pravastatin—atherosclerosis	0.000229	0.001	CcSEcCtD
Efavirenz—Rash—Pravastatin—atherosclerosis	0.000227	0.000994	CcSEcCtD
Efavirenz—Dermatitis—Pravastatin—atherosclerosis	0.000227	0.000994	CcSEcCtD
Efavirenz—Headache—Pravastatin—atherosclerosis	0.000225	0.000988	CcSEcCtD
Efavirenz—Nausea—Niacin—atherosclerosis	0.000217	0.000952	CcSEcCtD
Efavirenz—Nausea—Pravastatin—atherosclerosis	0.000214	0.000937	CcSEcCtD
Efavirenz—CYP2C9—Metabolism—CYP27A1—atherosclerosis	1.85e-05	0.000401	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—LTA4H—atherosclerosis	1.84e-05	0.000399	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—ABCG8—atherosclerosis	1.84e-05	0.000399	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—LPA—atherosclerosis	1.83e-05	0.000398	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism of lipids and lipoproteins—LPL—atherosclerosis	1.82e-05	0.000395	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—SCARB1—atherosclerosis	1.78e-05	0.000387	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—BGN—atherosclerosis	1.78e-05	0.000385	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—atherosclerosis	1.78e-05	0.000385	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—FABP4—atherosclerosis	1.77e-05	0.000385	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—LCAT—atherosclerosis	1.77e-05	0.000385	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—PLA2G2A—atherosclerosis	1.77e-05	0.000384	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—APOA2—atherosclerosis	1.77e-05	0.000384	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—ALOX5AP—atherosclerosis	1.77e-05	0.000384	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—ALOX15—atherosclerosis	1.77e-05	0.000384	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	1.76e-05	0.000383	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—APOA5—atherosclerosis	1.76e-05	0.000382	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—ALOX5AP—atherosclerosis	1.75e-05	0.00038	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—PLA2G2A—atherosclerosis	1.75e-05	0.00038	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—ALOX15—atherosclerosis	1.75e-05	0.00038	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—APOA2—atherosclerosis	1.75e-05	0.00038	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—ABCG5—atherosclerosis	1.75e-05	0.000379	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—APOA4—atherosclerosis	1.74e-05	0.000378	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—ABCG5—atherosclerosis	1.73e-05	0.000376	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism of lipids and lipoproteins—CD36—atherosclerosis	1.73e-05	0.000375	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—CYP7A1—atherosclerosis	1.71e-05	0.000371	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	1.71e-05	0.000371	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—PLA2G1B—atherosclerosis	1.69e-05	0.000367	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—LPA—atherosclerosis	1.69e-05	0.000366	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—HMGCR—atherosclerosis	1.68e-05	0.000365	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	1.67e-05	0.000363	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—LPA—atherosclerosis	1.67e-05	0.000363	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	1.66e-05	0.00036	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	1.65e-05	0.000359	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—ALOX5—atherosclerosis	1.63e-05	0.000355	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—BGN—atherosclerosis	1.63e-05	0.000355	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism of lipids and lipoproteins—APOB—atherosclerosis	1.63e-05	0.000354	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—BGN—atherosclerosis	1.62e-05	0.000351	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—APOA5—atherosclerosis	1.62e-05	0.000351	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	1.61e-05	0.000349	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—APOA5—atherosclerosis	1.6e-05	0.000348	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—CYP27A1—atherosclerosis	1.58e-05	0.000343	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	1.56e-05	0.000338	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—PLA2G1B—atherosclerosis	1.56e-05	0.000338	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism of lipids and lipoproteins—LPL—atherosclerosis	1.56e-05	0.000338	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—PLA2G1B—atherosclerosis	1.54e-05	0.000335	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	1.53e-05	0.000331	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—atherosclerosis	1.52e-05	0.000329	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	1.51e-05	0.000328	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	1.51e-05	0.000328	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	1.51e-05	0.000327	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—ALOX5—atherosclerosis	1.5e-05	0.000326	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—ABCA1—atherosclerosis	1.5e-05	0.000325	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—ALOX5AP—atherosclerosis	1.5e-05	0.000325	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—APOA2—atherosclerosis	1.5e-05	0.000325	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—ALOX15—atherosclerosis	1.5e-05	0.000325	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—PLA2G2A—atherosclerosis	1.5e-05	0.000325	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—ALOX5—atherosclerosis	1.49e-05	0.000323	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—ABCG5—atherosclerosis	1.48e-05	0.000321	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism of lipids and lipoproteins—CD36—atherosclerosis	1.48e-05	0.000321	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—NAMPT—atherosclerosis	1.47e-05	0.000318	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	1.46e-05	0.000316	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—LIPC—atherosclerosis	1.46e-05	0.000316	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—ABCG1—atherosclerosis	1.46e-05	0.000316	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—APOC3—atherosclerosis	1.45e-05	0.000314	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—LDLR—atherosclerosis	1.44e-05	0.000312	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—LPA—atherosclerosis	1.43e-05	0.00031	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—CETP—atherosclerosis	1.41e-05	0.000305	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—BGN—atherosclerosis	1.38e-05	0.0003	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	1.38e-05	0.000299	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	1.37e-05	0.000298	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—APOA5—atherosclerosis	1.37e-05	0.000297	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—LCAT—atherosclerosis	1.37e-05	0.000297	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—FABP4—atherosclerosis	1.37e-05	0.000297	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—NAMPT—atherosclerosis	1.35e-05	0.000293	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—SCARB1—atherosclerosis	1.35e-05	0.000292	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—APOA4—atherosclerosis	1.34e-05	0.000291	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—LIPC—atherosclerosis	1.34e-05	0.000291	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—NAMPT—atherosclerosis	1.34e-05	0.00029	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—APOC3—atherosclerosis	1.33e-05	0.000289	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	1.33e-05	0.000289	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	1.33e-05	0.000288	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—LIPC—atherosclerosis	1.33e-05	0.000288	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—LDLR—atherosclerosis	1.32e-05	0.000287	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—APOC3—atherosclerosis	1.32e-05	0.000286	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—CYP7A1—atherosclerosis	1.32e-05	0.000286	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—PLA2G1B—atherosclerosis	1.32e-05	0.000286	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—LDLR—atherosclerosis	1.31e-05	0.000285	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	1.31e-05	0.000284	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	1.3e-05	0.000283	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—CETP—atherosclerosis	1.29e-05	0.000281	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	1.29e-05	0.00028	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	1.29e-05	0.00028	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—HMOX1—atherosclerosis	1.29e-05	0.000279	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—CETP—atherosclerosis	1.28e-05	0.000278	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—ALOX5—atherosclerosis	1.27e-05	0.000276	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—HMGCR—atherosclerosis	1.27e-05	0.000276	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—SCARB1—atherosclerosis	1.24e-05	0.000269	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—APOB—atherosclerosis	1.23e-05	0.000267	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—SCARB1—atherosclerosis	1.23e-05	0.000266	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—CYP27A1—atherosclerosis	1.22e-05	0.000265	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—GSTM1—atherosclerosis	1.2e-05	0.00026	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	1.19e-05	0.000259	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	1.18e-05	0.000255	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—LPL—atherosclerosis	1.18e-05	0.000255	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—HMGCR—atherosclerosis	1.17e-05	0.000254	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—HMGCR—atherosclerosis	1.16e-05	0.000252	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—APOA2—atherosclerosis	1.16e-05	0.000251	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—PLA2G2A—atherosclerosis	1.16e-05	0.000251	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—ALOX5AP—atherosclerosis	1.16e-05	0.000251	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—ALOX15—atherosclerosis	1.16e-05	0.000251	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—GPX1—atherosclerosis	1.15e-05	0.000249	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	1.15e-05	0.000249	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—NAMPT—atherosclerosis	1.14e-05	0.000248	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—ABCG5—atherosclerosis	1.14e-05	0.000248	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	1.14e-05	0.000246	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—LIPC—atherosclerosis	1.14e-05	0.000246	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—ABCA1—atherosclerosis	1.13e-05	0.000246	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—APOC3—atherosclerosis	1.13e-05	0.000245	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—LDLR—atherosclerosis	1.12e-05	0.000243	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—CD36—atherosclerosis	1.12e-05	0.000243	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—LPA—atherosclerosis	1.1e-05	0.000239	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—CETP—atherosclerosis	1.1e-05	0.000238	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—BGN—atherosclerosis	1.07e-05	0.000232	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—MTHFR—atherosclerosis	1.06e-05	0.00023	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—APOA5—atherosclerosis	1.06e-05	0.000229	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—SCARB1—atherosclerosis	1.05e-05	0.000228	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	1.05e-05	0.000227	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—ABCA1—atherosclerosis	1.04e-05	0.000226	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—PPARA—atherosclerosis	1.04e-05	0.000226	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—ABCA1—atherosclerosis	1.03e-05	0.000224	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	1.02e-05	0.000222	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—PLA2G1B—atherosclerosis	1.02e-05	0.000221	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—AGT—atherosclerosis	1.01e-05	0.000218	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—HMGCR—atherosclerosis	9.9e-06	0.000215	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—APOE—atherosclerosis	9.86e-06	0.000214	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—ALOX5—atherosclerosis	9.83e-06	0.000213	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—CAV1—atherosclerosis	9.77e-06	0.000212	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—APOA1—atherosclerosis	9.75e-06	0.000212	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—HMOX1—atherosclerosis	9.72e-06	0.000211	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—APOB—atherosclerosis	9.31e-06	0.000202	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—GSTM1—atherosclerosis	9.06e-06	0.000197	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—HMOX1—atherosclerosis	8.94e-06	0.000194	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	8.93e-06	0.000194	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—PIK3CG—atherosclerosis	8.9e-06	0.000193	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—LPL—atherosclerosis	8.89e-06	0.000193	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—HMOX1—atherosclerosis	8.86e-06	0.000192	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—ABCA1—atherosclerosis	8.83e-06	0.000192	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—NAMPT—atherosclerosis	8.82e-06	0.000191	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—LIPC—atherosclerosis	8.76e-06	0.00019	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—APOC3—atherosclerosis	8.71e-06	0.000189	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—GPX1—atherosclerosis	8.67e-06	0.000188	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—LDLR—atherosclerosis	8.65e-06	0.000188	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—PPARG—atherosclerosis	8.59e-06	0.000186	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—APOB—atherosclerosis	8.56e-06	0.000186	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—APOB—atherosclerosis	8.49e-06	0.000184	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—CETP—atherosclerosis	8.45e-06	0.000183	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—CD36—atherosclerosis	8.45e-06	0.000183	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—INS—atherosclerosis	8.42e-06	0.000183	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—GSTM1—atherosclerosis	8.33e-06	0.000181	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—GSTM1—atherosclerosis	8.26e-06	0.000179	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—LPL—atherosclerosis	8.18e-06	0.000177	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—LPL—atherosclerosis	8.11e-06	0.000176	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—SCARB1—atherosclerosis	8.09e-06	0.000176	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—MTHFR—atherosclerosis	8e-06	0.000174	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—GPX1—atherosclerosis	7.98e-06	0.000173	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—GPX1—atherosclerosis	7.91e-06	0.000172	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—PPARA—atherosclerosis	7.85e-06	0.00017	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—CD36—atherosclerosis	7.77e-06	0.000169	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—ALB—atherosclerosis	7.72e-06	0.000168	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—CD36—atherosclerosis	7.7e-06	0.000167	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—HMGCR—atherosclerosis	7.64e-06	0.000166	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—AGT—atherosclerosis	7.61e-06	0.000165	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—HMOX1—atherosclerosis	7.57e-06	0.000164	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—APOE—atherosclerosis	7.45e-06	0.000162	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—NOS3—atherosclerosis	7.39e-06	0.00016	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—CAV1—atherosclerosis	7.38e-06	0.00016	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—APOA1—atherosclerosis	7.37e-06	0.00016	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—MTHFR—atherosclerosis	7.36e-06	0.00016	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—MTHFR—atherosclerosis	7.3e-06	0.000158	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—APOB—atherosclerosis	7.25e-06	0.000157	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—PPARA—atherosclerosis	7.22e-06	0.000157	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—PPARA—atherosclerosis	7.16e-06	0.000155	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—GSTM1—atherosclerosis	7.06e-06	0.000153	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—AGT—atherosclerosis	7e-06	0.000152	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—AGT—atherosclerosis	6.94e-06	0.00015	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—LPL—atherosclerosis	6.93e-06	0.00015	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—APOE—atherosclerosis	6.85e-06	0.000149	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—ABCA1—atherosclerosis	6.81e-06	0.000148	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—APOE—atherosclerosis	6.8e-06	0.000147	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—CAV1—atherosclerosis	6.79e-06	0.000147	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—APOA1—atherosclerosis	6.78e-06	0.000147	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—GPX1—atherosclerosis	6.76e-06	0.000147	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—PTGS2—atherosclerosis	6.76e-06	0.000147	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—CAV1—atherosclerosis	6.73e-06	0.000146	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—PIK3CG—atherosclerosis	6.73e-06	0.000146	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—APOA1—atherosclerosis	6.72e-06	0.000146	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—CD36—atherosclerosis	6.58e-06	0.000143	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—PPARG—atherosclerosis	6.49e-06	0.000141	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—INS—atherosclerosis	6.37e-06	0.000138	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—MTHFR—atherosclerosis	6.24e-06	0.000135	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—PIK3CG—atherosclerosis	6.19e-06	0.000134	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—PIK3CG—atherosclerosis	6.13e-06	0.000133	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—PPARA—atherosclerosis	6.12e-06	0.000133	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—PPARG—atherosclerosis	5.97e-06	0.00013	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—AGT—atherosclerosis	5.93e-06	0.000129	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—PPARG—atherosclerosis	5.92e-06	0.000128	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—INS—atherosclerosis	5.86e-06	0.000127	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—HMOX1—atherosclerosis	5.85e-06	0.000127	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—ALB—atherosclerosis	5.84e-06	0.000127	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—APOE—atherosclerosis	5.81e-06	0.000126	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—INS—atherosclerosis	5.8e-06	0.000126	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—CAV1—atherosclerosis	5.75e-06	0.000125	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—APOA1—atherosclerosis	5.74e-06	0.000125	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—APOB—atherosclerosis	5.6e-06	0.000122	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—NOS3—atherosclerosis	5.58e-06	0.000121	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—GSTM1—atherosclerosis	5.45e-06	0.000118	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—ALB—atherosclerosis	5.37e-06	0.000116	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—LPL—atherosclerosis	5.35e-06	0.000116	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—ALB—atherosclerosis	5.32e-06	0.000115	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—PIK3CG—atherosclerosis	5.24e-06	0.000114	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—GPX1—atherosclerosis	5.22e-06	0.000113	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—NOS3—atherosclerosis	5.14e-06	0.000111	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—PTGS2—atherosclerosis	5.11e-06	0.000111	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—NOS3—atherosclerosis	5.09e-06	0.00011	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—CD36—atherosclerosis	5.08e-06	0.00011	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—PPARG—atherosclerosis	5.06e-06	0.00011	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—INS—atherosclerosis	4.96e-06	0.000108	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—MTHFR—atherosclerosis	4.81e-06	0.000104	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—PPARA—atherosclerosis	4.72e-06	0.000102	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—PTGS2—atherosclerosis	4.7e-06	0.000102	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—PTGS2—atherosclerosis	4.66e-06	0.000101	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—AGT—atherosclerosis	4.57e-06	9.93e-05	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—ALB—atherosclerosis	4.55e-06	9.87e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—APOE—atherosclerosis	4.48e-06	9.72e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—CAV1—atherosclerosis	4.44e-06	9.64e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—APOA1—atherosclerosis	4.43e-06	9.61e-05	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—NOS3—atherosclerosis	4.35e-06	9.44e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—PIK3CG—atherosclerosis	4.04e-06	8.78e-05	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—PTGS2—atherosclerosis	3.98e-06	8.63e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—PPARG—atherosclerosis	3.9e-06	8.47e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—INS—atherosclerosis	3.83e-06	8.31e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—ALB—atherosclerosis	3.51e-06	7.62e-05	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—AKT1—atherosclerosis	3.4e-06	7.37e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—NOS3—atherosclerosis	3.36e-06	7.29e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—PTGS2—atherosclerosis	3.07e-06	6.66e-05	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—AKT1—atherosclerosis	2.57e-06	5.57e-05	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—AKT1—atherosclerosis	2.36e-06	5.12e-05	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—AKT1—atherosclerosis	2.34e-06	5.08e-05	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—AKT1—atherosclerosis	2e-06	4.34e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—AKT1—atherosclerosis	1.54e-06	3.35e-05	CbGpPWpGaD
